People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Accutar Biotechnology Inc. | — | Biotechnology | Series B | $76.5M | $940.7M | 2019 |
| Tiger Biotherapeutics Inc. | — | Other Technology | Series B | $20.0M | $234.1M | 2023 |
Jie FAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jie FAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Quan Zhou | 2 | 5 |
| BIHUA CHEN | 1 | 14 |
| Wei He | 1 | 3 |
| Yimin Qian | 1 | 1 |
| Xiangyan Sun | 1 | 1 |
| Long Zhu | 1 | 1 |
| Ke Liu | 1 | 1 |
| Ling Zou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.